Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells

引用本文：	W?sierska-G?dek J,Gritsch D,Zulehner N,Komina O,Maurer M.Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells[J].Journal of cellular biochemistry,2011,112(3):761-772.

作者姓名：	W?sierska-G?dek J Gritsch D Zulehner N Komina O Maurer M

摘要：
本文献已被 PubMed 等数据库收录！